Publication | Open Access
<i>SULF2</i> strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus
40
Citations
31
References
2013
Year
These findings implicate SULF2 as potential therapeutic target in the atherogenic dyslipidemia of obesity and T2DM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1